Guardian Pharmacy Services, Inc.
GRDN
$26.03
-$0.20-0.76%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.76% | 19.57% | 20.46% | 19.66% | 18.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.76% | 19.57% | 20.46% | 19.66% | 18.39% |
| Cost of Revenue | 15.68% | 20.27% | 19.86% | 20.41% | 17.54% |
| Gross Profit | 11.19% | 16.78% | 22.95% | 16.64% | 21.79% |
| SG&A Expenses | 25.00% | 14.28% | 194.24% | 182.78% | 69.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.09% | 19.26% | 31.10% | 55.72% | 23.26% |
| Operating Income | -19.95% | 27.53% | -45.62% | -1,552.65% | -25.54% |
| Income Before Tax | 140.95% | 204.15% | 11.42% | -1,410.24% | -78.63% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 68.97% | 115.20% | -18.67% | -1,412.75% | -78.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 103.89% | 104.06% | 104.01% | -58.86% | -75.77% |
| Net Income | -- | -- | -0.62% | -897.70% | -100.00% |
| EBIT | -19.95% | 27.53% | -45.62% | -1,552.65% | -25.54% |
| EBITDA | -13.25% | 22.31% | -39.69% | -5,787.65% | -20.22% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | 62.85% | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | 59.92% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 1.48% | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 3.37% | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | 0.81% | -- |